000			05859cam a2200757 i 4500
001			ocn957997445
003			OCoLC
005			20240925163918.0
006			m d
007			cr |||||||||||
008			160503s2016 nyu ob 001 0 eng
010			_a 2019716120
040			_aDLC _beng _erda _epn _cDLC _dEBLCP _dN$T _dYDX _dAGLDB _dSNK _dDKU _dAUW _dINTCL _dMHW _dBTN _dIGB _dD6H _dVTS _dAU@ _dG3B _dS8J _dS9I _dSTF _dVLY _dOCLCO _dOCLCQ _dOCLCO
019			_a961204944
020			_a9781634853774 _q(pdf)
020			_a1634853776
020			_z9781634853668 _q(hardcover)
020			_z1634853660 _q(hardcover)
035			_a1345681 _b(N$T)
035			_a(OCoLC)957997445 _z(OCoLC)961204944
050	0	0	_aRC801
060		4	_aWI 140
072		7	_aHEA _x039000 _2bisacsh
072		7	_aMED _x014000 _2bisacsh
072		7	_aMED _x022000 _2bisacsh
072		7	_aMED _x112000 _2bisacsh
072		7	_aMED _x045000 _2bisacsh
082	0	0	_a616.3/3 _223
049			_aMAIN
245	0	0	_aDisorders of gastrointestinal systems and clinical manifestations / _cSenthilkumar Rajagopal, PhD, Sengottuvelan Murugan, PhD and Saravanan Ramachandran, PhD, editors.
264		1	_aNew York : _bNova Biomedical, _c[2016]
300			_a1 online resource
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_adata file
490	1		_aDigestive diseases--research and clinical developments
504			_aIncludes bibliographical references and index.
588	0		_aPrint version record.
505	0		_aDISORDERS OF GASTROINTESTINAL SYSTEMS AND CLINICAL MANIFESTATIONS; DISORDERS OF GASTROINTESTINAL SYSTEMS AND CLINICAL MANIFESTATIONS; Library of Congress Cataloging-in-Publication Data; CONTENTS; ACKNOWLEDGMENTS; FOREWORD A; Dr. P. Madeswaran, PhD; FOREWORD B; Palok Aich, PhD, ; FOREWORD C; Qazi A. Hamid, Ph. D., ; ABOUT THE EDITORS; Dr. Senthilkumar Rajagopal; Dr. Sengottuvelan Murugan; Dr. Saravanan Ramachandran; SYNOPSIS; Chapter 1: UNDERSTANDING THE IMPACTS OF ALCOHOL: GASTRIC FUNCTIONS AND THERAPY; ABSTRACT; 1. INTRODUCTION; 2. THE GASTROINTESTINAL TRACT; 2.1. Stomach; 2.2. Acute Gastritis
505	8		_a2.3. Chronic Gastritis2.4. Consequences; 3. THERAPY; 3.1. How Is Acute Gastritis Diagnosed?; 3.1.1. How Is Acute Gastritis Treated?; 3.2. How Is Chronic Gastritis Diagnosed?; 3.2.1. The Most Common Medicines to Reduce Gastric Acid Are; 3.2.2. Diet; 3.2.3. Recommended Foods Generally Include Foods with Small Amounts of the Following; 3.2.4. Recommended Foods Include; SUMMARY; ACKNOWLEDGMENTS; REFERENCES; Chapter 2: RESVERATROL AND ITS DERIVATIVES FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS: A REVIEW; ABSTRACT; INTRODUCTION; STRUCTURE OF RESVERATROL AND ITS DERIVATIVES
505	8		_aRESVERATROL AND ITS DERIVATIVES IN ULCERATIVE COLITIS (UC)Resveratrol and Its Derivatives in Colon Cancer; Effects of Resveratrol and Its Derivatives on Colon Cancer Cells In Vitro; Effects of Resveratrol and Its Derivatives on Animal Models of Colon Cancer; EFFECTS OF RESVERATROL AND ITS DERIVATIVES ON ESOPHAGEAL AND STOMACH CANCER; CONCLUSION; REFERENCES; Chapter 3: ANTI-INFLAMMATORY EFFECT OF POLYMER FROM CEPHALOPOD AGAINST EXPERIMENTALLY INDUCED INTESTINAL BOWEL DISEASE IN ZEBRA FISH MODEL; ABSTRACT; 1. INTRODUCTION; 1.1. Types of IBD; 1.1.1. Crohn's Disease (CD)
505	8		_a1.1.2. Ulcerative Colitis (UC)1.1.3. Indeterminate Colitis (IC); 1.2. Historical Perspective and Research Advances; 1.3. Does an Environmental Factor Play a Role in IBD?; 1.4. "Westernization"; 1.5. Sanitation and Exposure to Infection; 1.6. Occupation; 1.7. Diet; 1.8. Tobacco Smoking; 1.9. Genetic Factors; 1.10. Familial and Ethnic Syndromes; 2. CURRENT LIMITATIONS OF IBD TREATMENT; 3. DRUG DISCOVERY AND ZEBRA FISH RESEARCH; 3.1. Zebra Fish -- Inflammation Research; 4. MICROBES CAUSING INFLAMMATION; 5. EXPERIMENTAL SETUP
505	8		_a5.1. Extraction and Isolation of Fractionated Glycosaminoglycans (f-GAG)5.2. Maintenance of Stocks and Collection of Embryos; 5.3. Induction of IBD; 5.4. Optical Observation; 5.5. Histology and Staining; 5.6. Alcian Blue Staining; 5.7. Sudan Black Staining; 5.8. Antibacterial Activity; 5.9. Antibacterial Susceptibility Testing; 5.10. Statistics; 6. RESULTS AND DISCUSSION; 6.1. Optical Observation; 6.2. Histology; 6.3. Alcian Blue Staining; 6.4. Antibacterial Activity of f-GAG; 7. HYPOTHETICAL MECHANISM OF ACTION; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES
590			_aWorldCat record variable field(s) change: 650
650		0	_aGastrointestinal system _xDiseases _xPathophysiology. _9832885
650		0	_aGastrointestinal system _xDiseases. _9135299
650		2	_aGastrointestinal Diseases _xphysiopathology _991450
650		2	_aGastrointestinal Diseases _980993
650		6	_aTractus gastro-intestinal _xMaladies. _9136463
650		7	_aHEALTH & FITNESS _xDiseases _xGeneral. _2bisacsh
650		7	_aMEDICAL _xClinical Medicine. _2bisacsh
650		7	_aMEDICAL _xDiseases. _2bisacsh
650		7	_aMEDICAL _xEvidence-Based Medicine. _2bisacsh
650		7	_aMEDICAL _xInternal Medicine. _2bisacsh
700	1		_aRajagopal, Senthilkumar, _eeditor. _9832886
700	1		_aMurugan, Sengottuvelan, _eeditor. _9832887
700	1		_aRamachandran, Saravanan, _eeditor. _9832888
776	0	8	_iPrint version: _tDisorders of gastrointestinal systems and clinical manifestations. _dNew York : Nova Biomedical, [2016] _z9781634853668 _w(DLC) 2016940560
830		0	_aDigestive diseases--research and clinical developments series. _9554895
856	4	0	_3EBSCOhost _uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1345681
938			_aProQuest Ebook Central _bEBLB _nEBL4691155
938			_aEBSCOhost _bEBSC _n1345681
938			_aYBP Library Services _bYANK _n13052454
994			_a92 _bN$T
999			_c711276 _d711276